Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Breast 1

Conditions

Motor Activity 1Leukemia, Myeloid, Acute 1Fatigue 1Breast Cancer With Chronic Lymphedema 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Completed × Waiting Lists × Clear all
NCT01706081 2019-08-29

Acupuncture for Chronic Lymphedema

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
82 enrolled 10 charts
Breast

Breast Cancer With Chronic Lymphedema

NCT00764231 2012-02-08

A Study of a Home-based Exercise Intervention for Patients With Acute Myeloid Leukaemia (AML)

Toronto Rehabilitation Institute

Phase 2 Completed
40 enrolled
Other hematologic neoplasm

Fatigue, Motor Activity, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡